Antiviral and immunomodulating activities of chemically synthesized lipid A-subunit analogues GLA-27 and GLA-60.

Biological and antiviral activities of chemically synthesized lipid A-subunit analogues, GLA-27 and GLA-60, were investigated with respect to defense mechanisms such as macrophage and natural killer (NK) cell activation and interferon (IFN)-inducing activity. GLA-27, a 4-O-phosphono-D-glucosamine derivative carrying 3-O-tetradecanoyl (C14) and 2-N-3-tetradecanoyloxytetradecanoyl (C14-O-(C14] group, and GLA-60, a similar analogue carrying 3-O-linked C14-O-(C14) and 2-N-linked 3-hydroxytetradecanoyl (C14-OH) groups, strongly inhibited the formation of pox tail lesions and the growth of vaccinia virus at the tail lesion sites in infected mice. The antiviral activity of GLA-60 was about 1000-fold higher than that of muramyldipeptide (MDP), a representative immunomodulator. GLA-27 and GLA-60 had stronger immunomodulating activity than MDP in macrophage activation, NK cell activation and IFN-inducing activity, although it was weaker than natural lipid A. Toxic manifestations such as pyrogenicity, local Schwartzman reaction and lethality were far less pronounced for GLA-27 and GLA-60 than for natural lipid A.
AuthorsS Ikeda, C Nishimura, M Nakatsuka, J Y Homma, M Kiso, A Hasegawa
JournalAntiviral research (Antiviral Res) 1988 Jan-Feb Vol. 9 Issue 1-2 Pg. 37-46 ISSN: 0166-3542 [Print] NETHERLANDS
PMID3389769 (Publication Type: Journal Article)
Chemical References
  • Adjuvants, Immunologic
  • Antiviral Agents
  • Interferon Inducers
  • Lipid A
  • GLA 60
  • Acetylmuramyl-Alanyl-Isoglutamine
  • GLA 27
  • Acetylmuramyl-Alanyl-Isoglutamine (pharmacology)
  • Adjuvants, Immunologic
  • Animals
  • Antiviral Agents
  • Female
  • In Vitro Techniques
  • Interferon Inducers
  • Killer Cells, Natural (drug effects)
  • Lipid A (analogs & derivatives, pharmacology, toxicity)
  • Macrophage Activation (drug effects)
  • Male
  • Mice
  • Rabbits
  • Vaccinia virus (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: